Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05617911 · ClinicalTrials.gov registry record · NA
Clinical Comparison of Patellofemoral Pain Syndrome Outcomes After Blood Flow Restriction Therapy
A NA study, sponsored by Gaylord Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT05617911 is a NA study that was terminated before completion, run by Gaylord Hospital. The registered enrollment target is 1 participants.
The verdict
NCT05617911, a NA study, was terminated before completion, sponsored by Gaylord Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Blood Flow Restriction therapy improves patient related outcomes in those diagnosed with Patellofemoral Pain Syndrome compared to those in the sham comparator control group.
Interventions
- DEVICE Blood Flow Restriction Cuff
- PROCEDURE Sham and standard of Care Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-11-15 |
| Est. Completion | 2023-10-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05617911
The ClinicalTrials.gov registry entry for NCT05617911 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gaylord Hospital, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood Flow Restriction Cuff is the first listed.
NCT05617911 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05617911 about?
NCT05617911 is a clinical study titled "Clinical Comparison of Patellofemoral Pain Syndrome Outcomes After Blood Flow Restriction Therapy". The purpose of this study is to determine if Blood Flow Restriction therapy improves patient related outcomes in those diagnosed with Patellofemoral Pain Syndrome compared to those in the sham comparator control group.
What is the current status of trial NCT05617911?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2022-11-15. Estimated completion is 2023-10-10.
What interventions are being tested in trial NCT05617911?
The interventions under investigation include: Blood Flow Restriction Cuff (DEVICE), Sham and standard of Care Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT05617911?
This trial is sponsored by Gaylord Hospital, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.